TITLE

BENCH TO BEDSIDE

AUTHOR(S)
Secko, David
PUB. DATE
October 2005
SOURCE
CMAJ: Canadian Medical Association Journal;10/25/2005, Vol. 173 Issue 9, p1023
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Presents the results of studies on the link between environmental toxins and Parkinson's disease and melanoma. Support for the hypothesis on the role of exposure to environmental toxins in the etiology of Parkinson's disease; Reason for the fact that melanoma is adept at metastasizing.
ACCESSION #
18599387

 

Related Articles

  • Archives of Neurology: Study examines association between Parkinson disease, cancer.  // Biomedical Market Newsletter;8/28/2012, Vol. 21, p1 

    The article offers information on a study which revealed that patients with Parkinson disease are at a higher risk of developing prostate cancer and melanoma.

  • Parkinson's Disease-Related Protein, α-Synuclein, in Malignant Melanoma. Matsuo, Yasuhiro; Kamitani, Tetsu // PLoS ONE;2010, Vol. 5 Issue 5, p1 

    Background: Melanoma is the major cause of skin cancer death worldwide. Parkinson's disease is a neurodegenerative disorder that is caused by mutation of a-synuclein or other genes. Importantly, epidemiological studies have reported co-occurrence of melanoma and Parkinson's disease, suggesting...

  • Specific Pesticide-Dependent Increases in α-Synuclein Levels in Human Neuroblastoma (SH-SY5Y) and Melanoma (SK-MEL-2) Cell Lines. Chorfa, Areski; Bétemps, Dominique; Morignat, Eric; Lazizzera, Corinne; Hogeveen, Kevin; Andrieu, Thibault; Baron, Thierry // Toxicological Sciences;Jun2013, Vol. 133 Issue 2, p289 

    Epidemiological studies indicate a role of genetic and environmental factors in Parkinson’s disease involving alterations of the neuronal α-synuclein (α-syn) protein. In particular, a relationship between Parkinson’s disease and occupational exposure to pesticides has been...

  • Atypical cancer pattern in patients with Parkinson's disease. Olsen, J. H.; Friis, S.; Frederiksen, K.; McLaughlin, J. K.; Mellemkjaer, L.; Møller, H. // British Journal of Cancer;1/17/2005, Vol. 92 Issue 1, p201 

    Among 14 088 patients, with a primary diagnosis of Parkinson's disease during the period 1977-98 identified from the National Register of Patients, 1282 cancers were subsequently recorded in the Danish Cancer Registry, compared with 1464 expected, with a standardised incidence ratio (SIR) of...

  • Tumour progression: Disease connections. Alderton, Gemma K. // Nature Reviews Cancer;Oct2010, Vol. 10 Issue 10, p663 

    The article discusses the association of Parkinson's disease to cancer. It references the study "PARK2 deletions occur frequently in sporadic colorectal cancer and accelerate adenoma development in Apc mutant mice," by G. Poulogiannis and colleagues in the 2010 issue of "Proceeding of the...

  • Parkinson's disease linked to increased melanoma risk. Cona, Christen; Harris, Jason; Lawrence, Leah; Southall, Jennifer // Hem/Onc Today;3/25/2010, Vol. 11 Issue 6, p33 

    The article discusses research on the link between Parkinson's disease and melanoma risk, by J. M. Bertoni and colleagues, published in the 2010 issue of "Archives of Neurology."

  • NEWS brief.  // Dermatology Times;Mar2009, Vol. 30 Issue 3, p34 

    This section offers news briefs related to health and medicine as of March 2009. A public health advisory has been issued by the U.S. Food and Drug Administration (FDA) for the psoriasis drug Raptiva (efalizumab) from Genentech. A device is being developed for skin cancer detection without a...

  • Parkinson's link to melanoma.  // GP: General Practitioner;3/12/2010, p13 

    The article cites a research on melanomas prevalence in Parkinson's disease patients, published in a 2010 issue of the periodical "Archives of Neurology." It states in the study, researchers at the University of Nebraska, reported an increase of 124 percent in incidence of malignant melanomas...

  • Levodopa/carbidopa/rasagiline.  // Reactions Weekly;7/18/2009, Issue 1261, p19 

    The article describes the case of an 81-year-old woman who developed malignant melanoma after receiving levodopa/carbidopa and rasagiline for idiopathic Parkinson's disease. After 18 months of receiving the drugs, the patient presented with a pigmented lesion on her right cheek. She was...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics